 Russell Whelan
Concepts (112)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Immunoglobulin M | 1 | 2023 | 281 | 0.720 |
Why?
| | Kidney Diseases | 1 | 2023 | 427 | 0.590 |
Why?
| | Myocytes, Cardiac | 2 | 2013 | 538 | 0.460 |
Why?
| | Muscle, Smooth | 7 | 2004 | 153 | 0.420 |
Why?
| | Kidney | 1 | 2021 | 1495 | 0.380 |
Why?
| | Receptors, Adrenergic, beta | 1 | 2013 | 58 | 0.370 |
Why?
| | bcl-2-Associated X Protein | 1 | 2012 | 52 | 0.360 |
Why?
| | Cyclic AMP-Dependent Protein Kinases | 1 | 2013 | 125 | 0.360 |
Why?
| | Heart Diseases | 2 | 2012 | 341 | 0.310 |
Why?
| | Intracellular Signaling Peptides and Proteins | 1 | 2013 | 454 | 0.310 |
Why?
| | Cell Death | 1 | 2010 | 382 | 0.270 |
Why?
| | Bronchi | 3 | 2004 | 263 | 0.260 |
Why?
| | Myocardial Infarction | 4 | 2012 | 1209 | 0.260 |
Why?
| | Cardiac Output, Low | 1 | 2007 | 53 | 0.260 |
Why?
| | Interleukin-1 | 4 | 2004 | 961 | 0.240 |
Why?
| | Annexin A2 | 1 | 2025 | 15 | 0.230 |
Why?
| | Ventricular Remodeling | 1 | 2007 | 275 | 0.220 |
Why?
| | Mitochondria | 1 | 2012 | 984 | 0.220 |
Why?
| | Kidney Glomerulus | 1 | 2025 | 127 | 0.220 |
Why?
| | Complement Factor H | 1 | 2025 | 80 | 0.210 |
Why?
| | Proto-Oncogene Proteins | 1 | 2007 | 619 | 0.210 |
Why?
| | Heart Failure | 3 | 2013 | 2324 | 0.190 |
Why?
| | Necrosis | 3 | 2012 | 243 | 0.180 |
Why?
| | Epitopes | 1 | 2023 | 479 | 0.170 |
Why?
| | Doxorubicin | 1 | 2023 | 398 | 0.170 |
Why?
| | Membrane Proteins | 1 | 2007 | 1159 | 0.170 |
Why?
| | Mice, Inbred BALB C | 1 | 2023 | 1251 | 0.160 |
Why?
| | Trachea | 4 | 2002 | 258 | 0.150 |
Why?
| | Animals | 14 | 2025 | 37948 | 0.150 |
Why?
| | Immunoglobulin G | 1 | 2023 | 886 | 0.150 |
Why?
| | Creatinine | 1 | 2021 | 509 | 0.150 |
Why?
| | Renal Insufficiency | 1 | 2021 | 172 | 0.140 |
Why?
| | Autocrine Communication | 3 | 2002 | 38 | 0.130 |
Why?
| | Interleukin-5 | 5 | 2004 | 39 | 0.130 |
Why?
| | Apoptosis | 3 | 2012 | 2397 | 0.130 |
Why?
| | Glomerular Filtration Rate | 1 | 2021 | 764 | 0.130 |
Why?
| | Mice | 4 | 2025 | 18261 | 0.120 |
Why?
| | Rabbits | 7 | 2004 | 651 | 0.110 |
Why?
| | Adenosine Triphosphate | 2 | 2012 | 501 | 0.090 |
Why?
| | Mice, Knockout | 2 | 2025 | 3109 | 0.090 |
Why?
| | Immunoglobulin E | 2 | 2004 | 315 | 0.090 |
Why?
| | Autophagy | 2 | 2012 | 284 | 0.080 |
Why?
| | Mitochondria, Heart | 1 | 2010 | 101 | 0.070 |
Why?
| | Cytoskeletal Proteins | 1 | 2007 | 155 | 0.060 |
Why?
| | Signal Transduction | 3 | 2010 | 5185 | 0.060 |
Why?
| | Caspases | 1 | 2007 | 229 | 0.060 |
Why?
| | Humans | 12 | 2025 | 144667 | 0.050 |
Why?
| | Podocytes | 1 | 2025 | 80 | 0.050 |
Why?
| | Asthma | 4 | 2004 | 1774 | 0.050 |
Why?
| | Nerve Tissue Proteins | 1 | 2007 | 590 | 0.050 |
Why?
| | Tumor Suppressor Protein p53 | 1 | 2007 | 532 | 0.050 |
Why?
| | T-Lymphocytes | 2 | 2002 | 1984 | 0.050 |
Why?
| | Complement Activation | 1 | 2025 | 409 | 0.050 |
Why?
| | Hypersensitivity, Immediate | 1 | 2001 | 41 | 0.040 |
Why?
| | Gene Expression Regulation, Neoplastic | 1 | 2007 | 1437 | 0.040 |
Why?
| | Rhinovirus | 1 | 2001 | 60 | 0.040 |
Why?
| | Muscle Contraction | 2 | 2001 | 430 | 0.040 |
Why?
| | Picornaviridae Infections | 1 | 2001 | 53 | 0.040 |
Why?
| | Interleukin-13 | 1 | 2002 | 144 | 0.040 |
Why?
| | Syndrome | 1 | 2021 | 379 | 0.040 |
Why?
| | In Vitro Techniques | 4 | 2002 | 1046 | 0.040 |
Why?
| | Interleukin-10 | 1 | 2001 | 310 | 0.040 |
Why?
| | Dexamethasone | 1 | 2001 | 366 | 0.040 |
Why?
| | Endothelial Cells | 1 | 2025 | 864 | 0.040 |
Why?
| | Female | 2 | 2023 | 78304 | 0.030 |
Why?
| | Acetylcholine | 3 | 2002 | 208 | 0.030 |
Why?
| | Tumor Necrosis Factor-alpha | 1 | 2001 | 1207 | 0.030 |
Why?
| | Cytokines | 1 | 2004 | 2045 | 0.030 |
Why?
| | Breast Neoplasms | 1 | 2007 | 2365 | 0.030 |
Why?
| | Mice, Inbred C57BL | 1 | 2025 | 5967 | 0.030 |
Why?
| | Receptor-Interacting Protein Serine-Threonine Kinases | 1 | 2012 | 14 | 0.020 |
Why?
| | Gene Expression Regulation | 1 | 2001 | 2591 | 0.020 |
Why?
| | Mitochondrial Membrane Transport Proteins | 1 | 2012 | 46 | 0.020 |
Why?
| | Isoproterenol | 2 | 2001 | 96 | 0.020 |
Why?
| | Muscle Relaxation | 2 | 2001 | 28 | 0.020 |
Why?
| | Endoplasmic Reticulum | 1 | 2012 | 264 | 0.020 |
Why?
| | Reactive Oxygen Species | 1 | 2012 | 601 | 0.020 |
Why?
| | Karyopherins | 1 | 2007 | 20 | 0.020 |
Why?
| | Lymphocyte Activation | 2 | 2002 | 1124 | 0.020 |
Why?
| | Active Transport, Cell Nucleus | 1 | 2007 | 120 | 0.020 |
Why?
| | Dimerization | 1 | 2007 | 190 | 0.020 |
Why?
| | Receptors, Cytoplasmic and Nuclear | 1 | 2007 | 204 | 0.010 |
Why?
| | Protein Structure, Tertiary | 1 | 2007 | 849 | 0.010 |
Why?
| | RNA, Small Interfering | 1 | 2007 | 631 | 0.010 |
Why?
| | Adolescent | 2 | 2021 | 22409 | 0.010 |
Why?
| | Cells, Cultured | 2 | 2002 | 4110 | 0.010 |
Why?
| | RNA, Messenger | 2 | 2002 | 2815 | 0.010 |
Why?
| | Intracellular Membranes | 1 | 2002 | 76 | 0.010 |
Why?
| | Receptors, Interleukin-4 | 1 | 2002 | 16 | 0.010 |
Why?
| | Cholinergic Agents | 1 | 2002 | 18 | 0.010 |
Why?
| | Receptors, Interleukin-10 | 1 | 2001 | 7 | 0.010 |
Why?
| | GTP-Binding Protein alpha Subunits, Gi-Go | 1 | 2001 | 20 | 0.010 |
Why?
| | Vascular Cell Adhesion Molecule-1 | 1 | 2001 | 39 | 0.010 |
Why?
| | Receptors, Interleukin | 1 | 2001 | 43 | 0.010 |
Why?
| | Intercellular Adhesion Molecule-1 | 1 | 2001 | 129 | 0.010 |
Why?
| | Interleukin-4 | 1 | 2002 | 206 | 0.010 |
Why?
| | Transcription, Genetic | 1 | 2007 | 1468 | 0.010 |
Why?
| | Bronchodilator Agents | 1 | 2001 | 184 | 0.010 |
Why?
| | Protein Isoforms | 1 | 2002 | 396 | 0.010 |
Why?
| | Models, Biological | 1 | 2007 | 1811 | 0.010 |
Why?
| | Immunization | 1 | 2002 | 374 | 0.010 |
Why?
| | Cell Line, Tumor | 1 | 2007 | 3523 | 0.010 |
Why?
| | Cell Adhesion Molecules | 1 | 2001 | 178 | 0.010 |
Why?
| | Vasodilator Agents | 1 | 2001 | 329 | 0.010 |
Why?
| | Oligonucleotide Array Sequence Analysis | 1 | 2001 | 751 | 0.010 |
Why?
| | Cell Communication | 1 | 2001 | 325 | 0.010 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2001 | 2019 | 0.010 |
Why?
| | Mutation | 1 | 2007 | 4081 | 0.010 |
Why?
| | Gene Expression Profiling | 1 | 2001 | 1766 | 0.010 |
Why?
| | Transcription Factors | 1 | 2001 | 1726 | 0.010 |
Why?
| | Adult | 2 | 2002 | 40489 | 0.000 |
Why?
| | Male | 2 | 2002 | 72431 | 0.000 |
Why?
|
|
Whelan's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|